PCVX

Vaxcyte, Inc.

NasdaqHealthcareBiological Products, (No Diagnostic Substances)

Insider activity for last month from 09/19 to 10/19.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$3.33M4 sells
Net open-market−$3.33MBuying minus selling
Active insiders2Distinct reporting owners

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Oct 07, 2026

Open-market transaction mix · 4 transactions in the selected period
0 buys0%·100%4 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Sep 2026000$0$0$0
Oct 2026040$0$3.33M-$3.33M

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (2)
Sep 2026: 0 insidersOct 2026: 2 insiders
Sep 2026Oct 2026
2distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
2 insiders
  • WJ
    Wassil JimEVP, CSO, COO · 0 buys · 3 sells · 0 awards (A)
    -$1.6Mlast 10/07/2026
  • CE
    Cowan ElviaSVP, CAO · 0 buys · 1 sells · 0 awards (A)
    -$1.2Mlast 10/07/2026

PCVX transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
CompanyInsiderActivityDisclosed valueFiled (ET)
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOS · sale10b5-1 detectedSEC filing ↗-$1.56MView disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOM · exercise10b5-1 detectedSEC filing ↗$96.3kView disclosure →
PCVXVaxcyte, Inc.
Cowan ElviaSVP · CAOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
PCVXVaxcyte, Inc.
Cowan ElviaSVP · CAOS · sale10b5-1 detectedSEC filing ↗-$1.64MView disclosure →
PCVXVaxcyte, Inc.
Cowan ElviaSVP · CAOM · exercise10b5-1 detectedSEC filing ↗$492kView disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOM · exercise10b5-1 detectedDerivative securitySEC filing ↗$0View disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOS · sale10b5-1 detectedSEC filing ↗-$5.42kView disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOS · sale10b5-1 detectedSEC filing ↗-$122kView disclosure →
PCVXVaxcyte, Inc.
Wassil JimEVP · CSO · COOM · exercise10b5-1 detectedSEC filing ↗$12.0kView disclosure →
Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy-
Largest sale$1.64M
10b5-1 detected10
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
10transactionstxns
  • M · Option exercise · dominant6 · 60%
  • S · Open-market sells4 · 40%

Activity by reported role

A joint filing can contribute to multiple roles
COO7
CSO7
EVP7
CAO3
SVP3

Reported Holdings After

Separated by insider, security, and ownership type

Wassil JimCommon Stock · Direct
163.4k145.4kOct 01, 2026Oct 05, 2026
145,435Oct 05, 2026
Wassil JimStock Option (right to buy) · Direct
64.4k46.4kOct 01, 2026Oct 05, 2026
46,398Oct 05, 2026
Cowan ElviaCommon Stock · Direct
46.9k27.9kOct 05, 2026Oct 05, 2026
27,860Oct 05, 2026
Cowan ElviaStock Option (right to buy) · Direct
74.1k74.1kOct 05, 2026Oct 05, 2026
74,068Oct 05, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
2 active days
Sep 19 → Oct 19
LessMore

Vaxcyte, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Vaxcyte, Inc.?

Wassil Jim, Cowan Elvia.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Wassil Jim reported a sale on Oct 05, 2026 valued at $1.56M. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $3,336,893.30. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.